Roadmap: publish sequence-qualified viral coding references for cancer RNA and the GDC panel

未关闭
#91 1 条评论 0 个 reaction 已指派 0 人 在 GitHub 查看

维护者通常 1 天内回复

还没有人认领这个 Issue。

评估

难度
5/5
预计耗时
一周以上
新手友好度
8/100
Issue 类型
功能
描述清晰度
基本清楚
活跃度
活跃
领域
data

调研方向

This is a tracking roadmap, so start from a child issue rather than this one. The HPV16 seed (#92, shipped in ORFdata 0.29.0) shows the pattern: native SourceRNA and TranscriptORF objects, source-validated RefSeq CDSs, and the offline consumer example. Any new coverage must keep the pinned inventory SHA256 unchanged and match sequence content before transferring annotation.

由索引模型根据 Issue 内容生成。

描述

ORFdata should distribute versioned viral coding references that Isovar can apply to reconstructed sample RNA. This is reference annotation work, building on the existing native RNA/ORF models rather than introducing a viral ORF class hierarchy.

Deliverables

The first release should be the independently qualified HPV16 seed; the broader panel should not delay that small useful release.

Coverage and reference identity

Account for every one of the 200 viral contigs in GDC GRCh38.d1.vd1's published inventory: 189 HPV entries plus CMV, EBV, HBV, two HCV entries, HIV-1/2, KSHV, HTLV-1, Merkel cell polyomavirus and SV40. Report per-reference source accessions/versions, sequence identity, coding-model counts, available versus incomplete annotation, unresolved features and validation status. A contig being listed must not imply that its coding catalogue is complete.

Keep this historical GDC compatibility snapshot separate from explicitly selected, current strain/lineage expansions. Match actual sequence content, including circular rotation and strand when relevant, before transferring annotation. Never update historical checksums or apply new coordinates by virus name alone. The pinned inventory SHA256 used by Isovar is f221e758f47e4784714b4a89198b89536ddacdc905da9c778a6802d3e1e51c56.

Broader cancer coverage must include HDV, which is absent from that inventory. Maintain source-dated cancer-evidence and inclusion-reason metadata independently from sequence availability. IARC's June 2025 assessment classifies HDV and MCPyV as Group 1 and HCMV as Group 2B. NCI's infectious-agent overview supports prioritizing HPV, EBV, KSHV, HBV/HCV and HTLV-1. Do not label all GDC viruses as established human cancer causes or treat HIV-associated immunosuppression as proof that a tumor expresses an HIV target. Consider additional candidate viruses through evidence review, not an unsupported exhaustive-causality claim.

Shared contract and scope

  • Reuse SourceRNA, TranscriptORF.at, catalogue manifests/cache and existing provenance. Keep source RNA/CDS fragments distinct from fully defined transcripts; preserve ordered coding blocks, strand, phase, translation table and start/stop completeness.
  • Provide deterministic, explicitly installed, offline data selection by exact viral reference. Coordinate with #70/#71 without forcing viral inputs through a human/PyEnsembl-only entry point.
  • Reference coding annotation is distinct from reference protein FASTA layers already supported by ViralProteome. RNA support is distinct from direct translation or protein evidence.
  • Preserve unsupported recoding/processing explicitly and link #65/#67; ordinary source-validated CDS imports should ship independently.
  • Isovar owns observed RNA reconstruction, read support and sample-specific protein predictions. It must preserve variation and incomplete coding sequence rather than fill missing bases from reference. Downstream integration: openvax/isovar#465.

Acceptance: versioned reference releases, an offline consumer example using native ORFdata objects, qualified real-source fixtures, and a coverage manifest that exposes gaps. Keep the verified HPV16 smoke test available throughout expansion.

Seed release: ORFdata 0.29.0 is published, via #99 (closes #92). It provides nine source-validated RefSeq NC_001526.4 CDSs, qualified against both native and GDC HPV16 DNA. The downstream coding consumer is Isovar PR #516. Remaining family issues retain explicit coverage and unsupported-feature requirements.

主要语言
Python
星标
1
派生
1
平均合并
10 小时 11 分钟
30 天内合并 PR
51

环境准备

这个项目没有提供开发容器、Dockerfile 或贡献指南,环境需要你自己搭建:先看它的 README,通用步骤见我们的新手贡献指南。

从这里开始

  1. 先读完整个 Issue,再读项目的贡献指南。
  2. 在 Issue 下留言说明你要接手 —— 这能避免两个人做同样的事。
  3. Fork 仓库,在一个分支上完成修改。
  4. 提交 Pull Request,并在描述里引用这个 Issue 编号。

openvax/orfdata 的其他 Issue

查看 openvax/orfdata 的全部 Issue

相似的 Issue

更多 Python Issue

把新 issue 发到你的邮箱

精选适合新手参与的 GitHub issue 摘要。